Asana, Inc. SEC Filing

Morgan Stanley Smith Barney LLC submitted a Section 144 notice proposing the sale of 5,015 shares of Common Stock (restricted stock) with an effective date of 03/20/2026.

Accepted by SEC EDGAR 03/25/2026 - 04:11 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Section 144 notice proposing the sale of 5,015 shares of Common Stock (restricted stock) with an effective date of 03/20/2026.

The filing also lists recent reported sales by Katie Colendich: 7,304 shares on 03/10/2026, 3,575 shares on 03/20/2026, and 1,500 shares on 03/24/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002099916
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ASANA, INC.
SEC File Number	001-39495
Address of Issuer	633 Folsom Street, Suite 100 San Francisco CALIFORNIA 94107
Phone	(415) 525-3888
Name of Person for Whose Account the Securities are To Be Sold	KATIE COLENDICH
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5015	32196.30	162197788	03/25/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/20/2026	Restricted Stock	ISSUER			5015	03/20/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
KATIE COLENDICH 633 Folsom Street, Suite 100 San Francisco CA 94107	Common	03/24/2026	1500	9585.15
KATIE COLENDICH 633 Folsom Street, Suite 100 San Francisco CA 94107	Common	03/20/2026	3575	23764.46
KATIE COLENDICH 633 Folsom Street, Suite 100 San Francisco CA 94107	Common	03/10/2026	7304	54217.31

144: Remarks and Signature

Remarks
Date of Notice	03/25/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/27/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Katie Marie Colendich
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)